India gov't seals deal for 300m Biological-E COVID-19 vaccine doses

India's government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million).

>>Reuters
Published : 3 June 2021, 04:26 AM
Updated : 3 June 2021, 04:26 AM

The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a statement.